ArticleRSC advances2026
Synthesis of siloxane-integrated Schiff base compounds exhibiting aggregation-induced emission properties.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- "Turn-on" fluorescence sensor for ScRSC advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Schiff base compounds have garnered considerable research interest due to their promising fluorescence properties. In this work, we successfully synthesized two Schiff base compounds as aggregation-induced emission (AIE)-active luminescent agents using a simple and efficient one-step method. The molecular design of these compounds effectively combines the dual advantages of Schiff base structures and AIE effects, retaining the chemical stability and tunable optical properties of Schiff base compounds while exhibiting the unique AIE property of significantly enhanced fluorescence in the aggregated state. Owing to these AIE characteristics, the synthesized compounds show potential for application in biomedicine, including bioimaging, fluorescence sensing, and information security.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.